ArticleJournal of experimental & clinical cancer research : CR2019

Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation.

An-Yue Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.